Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Pfizer shares fall on guidance cut, weighing on BioNTech and Moderna stocks, and other shares on the move
06:10am, Monday, 16'th Oct 2023
Shares of Lululemon Athletica Inc. LULU, +1.00% rallied more than 5% after index provider S&P Dow Jones Indices said the stock will join the S&P 500 index SPX on Wednesday.
BioNTech will likely take 900 mln eur write-off on Pfizer-partnered vaccines
03:59am, Monday, 16'th Oct 2023
Germany's BioNTech on Monday said it would likely take write-downs of up to 900 million euros ($947 million) in the third quarter after its partner Pfizer reported similar charges on their COVID-19 va
Pfizer's Sequel: Return Of The Value Stock
02:53am, Monday, 16'th Oct 2023
Pfizer is focusing on its core growth engines and strategic acquisitions, particularly in the oncology segment, to compensate for downgraded revenue projections and a concerning debt profile. The comp
2 Dirt Cheap High-Yield Dividend Stocks to Buy Right Now
10:00am, Sunday, 15'th Oct 2023
Pfizer is on a roll of important approvals that will eventually fill the gap left by its coronavirus portfolio. Gilead Sciences has a deep lineup and pipeline that are especially concentrated around H
Pfizer: Buy This Big Pharma Stock For Safe Income And Deep Value
04:23am, Sunday, 15'th Oct 2023
Combining sustainable income and deep value is an investing strategy that can work very well over the long run. Pfizer's market-smashing dividend is comfortably covered by its adjusted diluted EPS. Th
Pfizer slashes outlook: Projects weak demand for Covid-19 vaccine and Paxlovid
08:31pm, Friday, 13'th Oct 2023
Hosted by Brian Sullivan, “Last Call” is a fast-paced, entertaining business show that explores the intersection of money, culture and policy. Tune in Monday through Friday at 7 p.m.
Pfizer Launches $3.5 Billion Cost-Cutting Program Amid Declining Covid Vaccine Sales
07:43pm, Friday, 13'th Oct 2023
The pharmaceutical company warned in January it expected revenue for its Covid vaccine and Paxlovid pill to drop sharply.
Pfizer slashes full-year earnings and revenue guidance as Covid treatment, vaccine sales slump
05:47pm, Friday, 13'th Oct 2023
Pfizer said it anticipates sales of its Covid treatment Paxlovid and its vaccine will be $9 billion less than it had expected.
Pfizer warns of delayed Paxlovid commercialization and lower Covid demand
05:16pm, Friday, 13'th Oct 2023
CNBC's Angelica Peebles joins 'Closing Bell: Overtime' to discuss Pfizer earnings.
Pfizer's stock sinks after company cuts outlook on lower demand for COVID products
04:44pm, Friday, 13'th Oct 2023
Pfizer Inc. PFE, -2.46% shares dropped in the extended session Friday after the drug maker slashed its full-year outlook due to COVID product write offs. Pfizer shares dropped more than 7% after hours
FDA Approves Pfizer's (PFE) Braftovi + Mektovi for Lung Cancer
01:31pm, Friday, 13'th Oct 2023
Pfizer's (PFE) Braftovi + Mektovi drug combo gets label expansion for BRAF V600E-mutant non-small cell lung cancer.
New RSV protections for infants hit cost, insurance hurdles in U.S. rollout
12:22pm, Friday, 13'th Oct 2023
Pfizer's maternal vaccine, Abrysvo, and Sanofi's monoclonal antibody, Beyfortus, were approved for expectant mothers and infants in the U.S. earlier this year.
U.S. FDA approves Pfizer's inflammatory bowel disease drug
09:09am, Friday, 13'th Oct 2023
Pfizer said on Friday that theU.S. Food and Drug Administration has approved its drug to treat adults with moderate-to-severe inflammatory bowel disease, ulcerative colitis.
EU regulator backs Pfizer's blood cancer therapy
08:05am, Friday, 13'th Oct 2023
The European Union medicines regulator on Friday recommended a conditional marketing authorization for U.S. drugmaker Pfizer's therapy for a type of blood cancer that is difficult to treat.
The Zacks Analyst Blog UnitedHealth, Chevron, AstraZeneca, Adobe and Pfizer
09:46am, Thursday, 12'th Oct 2023
UnitedHealth, Chevron, AstraZeneca, Adobe and Pfizer are part of the Zacks Analyst Blog.
